Page last updated: 2024-09-05

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Sarcoma

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide has been researched along with Sarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dittrich, C; Gneist, M; Huitema, AD; King, AA; Wanders, J; Zandvliet, AS1

Trials

1 trial(s) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Sarcoma

ArticleYear
A phase I and pharmacokinetic study of indisulam in combination with carboplatin.
    British journal of cancer, 2007, Feb-26, Volume: 96, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Sarcoma; Sulfonamides; Thrombocytopenia; Treatment Outcome

2007